Las enseñanzas de la pandemia | 23 JUN 20

Diez cosas que aprendimos sobre COVID-19

Una síntesis de la experiencia de los meses de pandemia en la asistencia de pacientes con distintas presentaciones clínicas
Autor/a: Cecconi, M., Forni, G. & Mantovani, A. Fuente: Intensive Care Med (2020). Ten things we learned about COVID-19
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Tai W et al (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol.
  2. Ferretti L et al (2020) Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science.
  3. Zhou F et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062
  4. Vabret N et al (2020) Immunology of COVID-19: current state of the science. Immunity.
  5. Sethuraman N, Jeremiah SS, Ryo A (2020) Interpreting diagnostic tests for SARS-CoV-2. JAMA.
  6. Lodigiani C et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9–14
  7. Varga Z et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417–1418
  8. Joly BS, Siguret V, Veyradier A (2020) Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med.
  9. WHO (2020) WHO “Immunity passports” in the context of COVID-19. Accessed 24 Apr 2020
  10. Lauer SA et al (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172(9):577–582
  11. Grasselli G et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA.
  12. Guan WJ et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720
  13. Alhazzani W et al (2020) Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46(5):854–887
  14. Lurie NM et al (2020) Developing Covid-19 vaccines at pandemic speed. N Engl J Med.
  15. Shadman Aziz YMA, Waleed A, Laura E, Giuseppe C, Katherine F et al (2020) Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med.
  16. Grasselli G, Pesenti A, Cecconi M (2020) Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 323(16):1545–1546.
  17. AA.VV (2020) REMAP-CAP response to novel COVID-10 pandemic.


Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas: